Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Neuropsychiatric Mechanisms of Change in Mentalization Based Treatment of Borderline Personality Disorder (MENTAB)

This study has been terminated.
Sponsor:
Collaborators:
Psychiatry Roskilde
University of Copenhagen
Psychiatric Epigenetics Laboratory, Institute of Psychiatry, UK
University of Southern Denmark
Psychoanalysis Unit, University College London, UK
Aarhus University Hospital
University College Zealand, Denmark
Research Division of Clinical Biochemistry, Koege Hospital, Denmark
Information provided by (Responsible Party):
Rune Andersen, Region Sjaelland
ClinicalTrials.gov Identifier:
NCT01720953
First received: October 26, 2012
Last updated: July 24, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)